Follicular Lymphoma


AEs prompt EMA review of idelalisib

Photo courtesy of Gilead Sciences, Inc. The European Medicines Agency (EMA) is reviewing the safety of idelalisib (Zydelig), a drug approved to...


NICE issues draft guideline for NHL

a cancer patient Photo courtesy of NCI/ Mathews Media Group The National Institute for Health and Care Excellence (NICE) has issued a draft...

Conference Coverage

EZH2 inhibitor can produce durable responses

ORLANDO, FL—Updated results of a phase 1 study suggest the EZH2 inhibitor tazemetostat (EPZ-6438) can produce durable responses in patients with...


Trial of ofatumumab in FL stopped early

Photo courtesy of GSK Genmab A/S said it is stopping a phase 3 trial of ofatumumab in follicular lymphoma (FL) after a planned interim analysis...